FutuRx
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Ilan Ramon St Fl 3, Ness Ziona, Centra...Phone Number
+972 89553100Website
www.futurx.co.ilRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About FutuRx
FutuRx is an incubator dedicated to transforming cutting-edge science into therapeutic breakthroughs by supporting early-stage biopharma ventures in successful drug development. Founded by Johnson & Johnson Innovation, Takeda Pharmaceutical Company, OrbiMed Israel Partners, and the Israeli Innovation Authority, it aims to foster innovation in the biopharmaceutical sector. The company collaborates with various partners, including Leaps by Bayer, to enhance its impact in the industry. FutuRx's primary clients are emerging biopharma companies seeking to advance their drug development processes.Explore more
FutuRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is FutuRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on FutuRx recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if FutuRx has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once FutuRx has new funding data
Check out if FutuRx is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if FutuRx had a recent Job posting/layoffs
Product Launch: Get notified when FutuRx launches new products
FutuRx, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at FutuRx
Recommended Actions
Find VP level buyers at FutuRx
Find more new buyers
Company Profile Activity
Activity Insights
FutuRx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
FutuRx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about FutuRx.
FutuRx Tech Stack
A closer look at the technologies used by FutuRx
FutuRx News & Media
Atomwise y FutuRx lanzan A2i Therapeutics - una nueva compañía de inmunooncología financiada por las principales empresas de capital riesgo del sector biofarmacéutico y la Autoridad de Innovación de Israel
SAN FRANCISCO & NESS ZIONA, Israel--(BUSINESS WIRE)--Atomwise, líder en el uso de la inteligencia artificial (IA) para el descubrimiento de fármacos de pequeñas moléculas, ha anunciado hoy una asociación con FutuRx, una reconocida incubadora de biotecnología con sede en Israel, centrada en tecnologías terapéuticas innovadoras en las primeras etapas. La colaboración servirá como la primera introducción de la plataforma AtomNet® de Atomwise para el descubrimiento de fármacos basados en la IA a unAtomwise en FutuRx lanceren A2i Therapeutics - een nieuw immuno-oncologiebedrijf gefinancierd door vooraanstaande Biopharma VC's en de Israeli Innovation Authority
SAN FRANCISCO en NESS ZIONA, Israël--(BUSINESS WIRE)--Atomwise, de marktleider van kunstmatige intelligentie (AI) voor geneesmiddelontwikkeling met kleine moleculen heeft vandaag een partnership aangekondigd met FutuRx, een erkende in Israël gevestigde biotechnologie-incubator die zich richt op innovatieve, therapeutische technologieën in een vroeg stadium van ontwikkeling. De samenwerking dient als de eerste introductie van Atomwise’s AtomNet® platform voor op AI gebaseerde geneesmiddelontdekkAtomwise und FutuRx gründen A2i Therapeutics, ein neues Immunonkologieunternehmen, das von führenden Biopharma-Wagniskapitalunternehmen und der israelischen Innovationsbehörde finanziert wird
SAN FRANCISCO und NESS ZIONA, Israel--(BUSINESS WIRE)--Atomwise, der Marktführer bei der Nutzung künstlicher Intelligenz (KI) für die Entdeckung niedermolekularer Wirkstoffe, hat heute eine Partnerschaft mit FutuRx, einem anerkannten Biotechnologie-Inkubator mit Sitz in Israel mit Schwerpunkt auf innovativen Technologien für die frühe therapeutische Phase, angekündigt. Die Kooperation wird eine erste Vorstellung der Plattform AtomNet® von Atomwise für die Wirkstoffentdeckung auf Grundlage von KAtomwise et FutuRx lancent A2i Therapeutics, une nouvelle société d’immuno-oncologie financée par plusieurs fonds biopharmaceutiques de capital-risque, de premier plan, et l’Autorité israélienne de l’innovation
SAN FRANCISCO et NESS ZIONA, Israël--(BUSINESS WIRE)--Atomwise, leader dans l’utilisation de l’intelligence artificielle (IA) pour la découverte de médicaments à petites molécules, a annoncé aujourd’hui un partenariat avec FutuRx, incubateur biotechnologique de renom, basé en Israël, et spécialisé dans les technologies thérapeutiques innovantes de stade précoce. Cette collaboration permettra de lancer pour la première fois la plateforme AtomNet® d’Atomwise, destinée à la découverte de médicamen
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding FutuRx
Sign Up For FreeTo access detailed company insights
FutuRx is an incubator dedicated to transforming cutting-edge science into therapeutic breakthroughs by supporting early-stage biopharma ventures in successful drug development. Founded by Johnson & Johnson Innovation, Takeda Pharmaceutical Company, OrbiMed Israel Partners, and the Israeli Innovation Authority, it aims to foster innovation in the b... Read More
